The Hematology Market - Global Growth, Trends and Forecasts to 2024 by Product, Reagent, Application, End-user and Geography - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--May 1, 2019--The “Hematology Market - Growth, Trends, and Forecast (2019 - 2024)” report has been added to ResearchAndMarkets.com’s offering.
The growth of the hematology market is attributed to the increasing incidences of blood disorders and other diseases, rapid technological advances in hematology, and the emergence of high throughput hematology analyzers.
Blood disorders have become a global health issue with different causes, and are associated with high mortality. Blood disorders, such as anemia, blood cancer, hemorrhagic conditions, and blood infections, affect millions of people each year across all age groups. According to WHO, hemoglobin disorders are potentially affecting 75% of births, globally, and sickle cell trait affects an estimated one in 12 African Americans.
Over 70% of all sickle-cell affected births occur in Africa. As per the World Health Organization, the prevalence of anemia in children is 47.4% and 12.7% in men, and it is increasing rapidly all over the world. According to the National Institute of Health (NIH), anemia affects 29% of women with reproductive age and 38% of pregnant women, worldwide.
About 400 babies are born with hemophilia, each year, in the United States. The global incidence of hemophilia is observed in more than 400,000 people. The most common blood disorder, venous thromboembolism, affects at least 1 million people in the United States and it is a major cause of death in adults. Leukemia, lymphoma, myeloma, and myelodysplastic syndromes are types of highly prevalent cancers.
Approximately every 3 minutes, one person in the United States is diagnosed with a type of blood cancer. The need to address the rising burden of blood disorders is increasing. Early diagnosis and treatment are the best ways to protect the quality of life for a patient with blood cell disorder.
Key Market Trends
The Patient Self-testing Segment, under End User is Expected to Grow at the Fastest Rate, during the Forecast Period
The clinical testing institutes segment held a maximum share in 2018, due to the increasing awareness for hematology testing, shift from manual testing to automated testing, and competitive benefits offered by these providers, as compared to hospitals (such as affordable service costs, efficient turnaround time, and efficient management for sample collection).
The patient self-testing segment is projected to show significant growth during the forecast period, owing to the growing cases of hematology disorders, such as anemia and iron deficiency, as well as infectious diseases.
The North American Region Holds the Largest Market Share and is Expected to Follow the Same Trend over the Forecast Period
Currently, North America is the largest market for hematology analyzers. This market trend can be attributed to the increasing incidence of blood disorders. The increasing cases of blood-related disorders, such as anemia, blood cancer, etc., may lead to the growth of the hematology market. Europe is the second-largest market, while Asia-Pacific is the fastest growing region.
The hematology market consists of several major players. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships, which help them in strengthening their market position. For instance, in November 2017, Sysmex acquired CLIA Waiver, for the New Automated Hematology Analyzer.
Key Topics Covered
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidences of Blood Disorders and Other Diseases
4.2.2 Rapid Technological Advances in Hematology
4.2.3 Emergence of High Throughput Hematology Analyzers
4.3 Market Restraints
4.3.1 High Cost of the Instruments
4.3.2 Low Adoption of Hematology Analyzers in Emerging Economies
4.4 Porter’s Five Forces Analysis
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Hematology Analyzers
5.1.2 Flow Cytometers
5.1.3 Coagulation Analyzers
5.1.4 Slide Stainers
5.1.7 Other Products
5.2 By Reagent
5.2.1 Coagulation Reagents
5.2.2 Flow Cytometery Reagents
5.2.3 Immuno-hematology Reagents
5.2.4 Other Reagents
5.3 By Application
5.3.1 Drug Testing
5.3.2 Auto Immune Disease
5.3.4 Diabetes Mellitus
5.3.5 Infectious Disease
5.3.6 Other Applications
5.4 By End User
5.4.2 Clinical Testing Institutes
5.4.3 Patient Self-testing
5.4.4 Other End Users
5.5.1 North America
5.5.4 Middle East & Africa
5.5.5 South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Agilent Technologies Inc.
6.1.3 Bio-Rad Laboratories Inc.
6.1.4 Danaher Corporation
6.1.5 Dolomite Centre
6.1.6 F.Hoffmann-La Roche AG
6.1.7 Novo Nordisk AS
6.1.8 Fluidigm Corporation
6.1.9 Micronit Microfluidics B.V.
6.1.10 PerkinElmer Inc.
6.1.11 Thermo Fisher Scientific Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/f80ho9
View source version on businesswire.com:https://www.businesswire.com/news/home/20190501005646/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH GENERAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 05/01/2019 09:48 AM/DISC: 05/01/2019 09:48 AM